Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say.
Published: April 15, 2018 at 02:00AM
from NYT Technology https://ift.tt/2vkhksw
Genetic disease risk screening is becoming a popular employee benefit. But the tests may not be all that beneficial for the general population, experts say.
Published: April 15, 2018 at 02:00AM
from NYT Technology https://ift.tt/2vkhksw
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google reCAPTCHA helps protect websites from spam and abuse by verifying user interactions through challenges.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)